\-\ Texto\\:\\ \ \(0\)\
\-\ physical\\ examination\\ reveals\\ no\\ focal\\ neurologic\\ deficit\\.\ \(0\)\
\-\ the\\ patient\\ underwent\\ tumor\\ resection\\ and\\ is\\ being\\ followed\\ up\\ with\\ serial\\ brain\\ mri\\ scans\\ to\\ assess\\ for\\ tumor\\ recurrence\\ or\\ tumor\\ progression\\ to\\ a\\ higher\\ grade\\ astrocytoma\\.\ \(0\)\
\-\ multiplanar\\ mr\\ imaging\\ demonstrates\\ the\\ presence\\ of\\ a\\ t1\\ hypointense\\ and\\ t2\\ \\,\\ flair\\ hyperintense\\ mass\\ lesion\\ in\\ the\\ medial\\ part\\ of\\ the\\ right\\ frontal\\ lobe\\.\\ the\\ mass\\ does\\ not\\ enhance\\ after\\ gadolinium\\ administration\\ and\\ exhibits\\ no\\ diffusion\\ restriction\\.\\ the\\ lesion\\ causes\\ mass\\ effect\\ on\\ the\\ corpus\\ callosum\\,\\ the\\ lateral\\ ventricles\\ and\\ the\\ left\\ frontal\\ lobe\\.\\ \ \(0\)\
\-\ almost\\ two\\ months\\ following\\ surgical\\ resection\\ of\\ the\\ right\\ frontal\\ mass\\,\\ postoperative\\ postcontrast\\ t1\\ weighted\\ images\\ demonstrate\\ no\\ overt\\ findings\\ of\\ residual\\ or\\ recurrent\\ tumor\\.\ \(0\)\
\-\ low\\ grade\\ \\(who\\ gr2\\)\\ \\ diffuse\\ astrocytoma\ \(0\)\
\-\ circumscribed\\ astrocytoma\\ \\(who\\ gr\\ 1\\)\ \(0\)\
\-\ diffuse\\ astrocytoma\\,\\ low\\ grade\\ \\(who\\ gr\\ 2\\)\\ \ \(0\)\
\-\ diffuse\\ astrocytoma\\,\\ anaplastic\\(who\\ gr\\ 3\\)\ \(0\)\
\-\ diffuse\\ astrocytoma\\,\\ glioblastoma\\ \\(who\\ gr\\ 4\\)\ \(0\)\
\-\ oligodendroglioma\\ \\(who\\ gr\\ 2\\,\\ 3\\)\ \(0\)\
\-\ oligo\\-astrocytoma\\ \\(who\\ gr\\ 2\\,3\ \(0\)\
\-\ ganglioglioma\\ \\(who\\ gr\\ 2\\)\ \(0\)\
\-\ cerebritis\ \(9\)\
\-\ ischemic\\ infarct\ \(7\)\
\-\ changes\\ from\\ seizures\\ or\\ status\\ epilepticus\ \(1\)\
\-\ a\\ 38\\ y\\.o\\.\\ woman\\ presents\\ with\\ a\\ 5\\-month\\ history\\ of\\ seizures\\ and\\ \\ gradual\\ onset\\ of\\ behavioral\\ changes\\.\ \(0\)\
\-\ advanced\\ mr\\ imaging\\ \\,\\ such\\ as\\ dynamic\\ susceptiblity\\ contrast\\ mr\\ imaging\\ and\\/or\\ mr\\ spectrocopy\\ \\,\\ was\\ not\\ used\\ in\\ this\\ case\\,\\ for\\ unknown\\ reasons\\.\\ nevertheless\\,\\ the\\ morphologic\\-anatomic\\ imformation\\ derived\\ from\\ t2\\-weighted\\ images\\,\\ flair\\ images\\ and\\ t1\\-weighted\\ images\\ \\(conventional\\ imaging\\)\\ \\,\\ the\\ contrast\\-enhancement\\ features\\ and\\ the\\ information\\ about\\ molecular\\ diffusion\\ \\(dwi\\)\\ \\ are\\ very\\ important\\ findings\\ and\\ more\\ compatible\\ with\\ a\\ low\\ grade\\ primary\\ brain\\ neoplasm\\ \\(low\\ grade\\ astrocytoma\\ \\-\\ lga\\)\\.\ \(0\)\
\-\ a\\ major\\ differential\\ diagnosis\\ problem\\ would\\ be\\ anaplastic\\ astrocytoma\\ \\(aa\\)\\.\\ it\\ is\\ \\ difficult\\ to\\ distinguish\\ aa\\ from\\ lga\\ on\\ the\\ basis\\ of\\ imaging\\ findings\\ alone\\.\\ definitive\\ diagnosis\\ would\\ require\\ biopsy\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ gr\\:\\ 0\\.1285729723771642\ \(0\)\
\-\ astrocytoma\\:\\ 0\\.08068936653308927\ \(0\)\
\-\ who\\:\\ 0\\.05417552362654594\ \(0\)\
\-\ lga\\:\\ 0\\.05358977765329178\ \(0\)\
\-\ grade\\:\\ 0\\.049465604756093774\ \(0\)\
\-\ aa\\:\\ 0\\.033333215281406044\ \(0\)\
\-\ mr\\:\\ 0\\.03301154373187154\ \(0\)\
\-\ anaplastic\\:\\ 0\\.03271447549836688\ \(0\)\
\-\ diffuse\\:\\ 0\\.03145297775532298\ \(0\)\
\-\ imaging\\:\\ 0\\.030426653867106423\ \(0\)\
\-\ low\\:\\ 0\\.02888958118986504\ \(0\)\
\-\ gr2\\:\\ 0\\.02679488882664589\ \(0\)\
\-\ susceptiblity\\:\\ 0\\.02679488882664589\ \(0\)\
\-\ spectrocopy\\:\\ 0\\.02679488882664589\ \(0\)\
\-\ morphologic\\-anatomic\\:\\ 0\\.02679488882664589\ \(0\)\
\-\ imformation\\:\\ 0\\.02679488882664589\ \(0\)\
\-\ \\(\\:\\ 0\\.026347540166949318\ \(0\)\
\-\ oligo\\-astrocytoma\\:\\ 0\\.024688058490597426\ \(0\)\
\-\ 5\\-month\\:\\ 0\\.024688058490597426\ \(0\)\
\-\ frontal\\:\\ 0\\.02447682615030417\ \(0\)\
\-\ tumor\\:\\ 0\\.024221669320496186\ \(0\)\
\-\ \\)\\:\\ 0\\.023856883322937252\ \(0\)\
\-\ flair\\:\\ 0\\.02381567552593062\ \(0\)\
\-\ contrast\\-enhancement\\:\\ 0\\.02345564174862732\ \(0\)\
\-\ diffusion\\:\\ 0\\.023252801441870894\ \(0\)\
\-\ epilepticus\\:\\ 0\\.02258122815454896\ \(0\)\
\-\ seizures\\:\\ 0\\.022333464239901752\ \(0\)\
\-\ behavioral\\:\\ 0\\.021902980278213975\ \(0\)\
\-\ overt\\:\\ 0\\.021348811412578855\ \(0\)\
\-\ 2\\,3\\:\\ 0\\.02047439781850049\ \(0\)\
\-\ images\\:\\ 0\\.019930260084490628\ \(0\)\
\-\ molecular\\:\\ 0\\.019796149942165508\ \(0\)\
\-\ nevertheless\\:\\ 0\\.019506453347015586\ \(0\)\
\-\ derived\\:\\ 0\\.01877343797675149\ \(0\)\
\-\ postcontrast\\:\\ 0\\.018563733200195404\ \(0\)\
\-\ would\\:\\ 0\\.018486120841471672\ \(0\)\
\-\ cerebritis\\:\\ 0\\.018367567482452028\ \(0\)\
\-\ restriction\\:\\ 0\\.017541021234781382\ \(0\)\
\-\ exhibits\\:\\ 0\\.01739962301096712\ \(0\)\
\-\ 2\\:\\ 0\\.01677906835723902\ \(0\)\
\-\ multiplanar\\:\\ 0\\.01677714759259018\ \(0\)\
\-\ dynamic\\:\\ 0\\.01677714759259018\ \(0\)\
\-\ gradual\\:\\ 0\\.016666607640703022\ \(0\)\
\-\ findings\\:\\ 0\\.016585139232127292\ \(0\)\
\-\ t1\\:\\ 0\\.016465018457290235\ \(0\)\
\-\ resection\\:\\ 0\\.016200095170335677\ \(0\)\
\-\ distinguish\\:\\ 0\\.015819454441709038\ \(0\)\
\-\ brain\\:\\ 0\\.01563131625108062\ \(0\)\
\-\ basis\\:\\ 0\\.015582489270068577\ \(0\)\
\-\ reasons\\:\\ 0\\.015434190898732917\ \(0\)\
\-\ ganglioglioma\\:\\ 0\\.015292792674918653\ \(0\)\
\-\ oligodendroglioma\\:\\ 0\\.015224486122176835\ \(0\)\
\-\ postoperative\\:\\ 0\\.015092312529654832\ \(0\)\
\-\ changes\\:\\ 0\\.014887829642766326\ \(0\)\
\-\ conventional\\:\\ 0\\.014727132250499625\ \(0\)\
\-\ mass\\:\\ 0\\.01444937394465124\ \(0\)\
\-\ compatible\\:\\ 0\\.014350072528098473\ \(0\)\
\-\ glioblastoma\\:\\ 0\\.014299831488733091\ \(0\)\
\-\ t1\\-weighted\\:\\ 0\\.014250407413134974\ \(0\)\
\-\ problem\\:\\ 0\\.014201774156762813\ \(0\)\
\-\ information\\:\\ 0\\.014153906810355095\ \(0\)\
\-\ alone\\:\\ 0\\.014060375932948548\ \(0\)\
\-\ lobe\\:\\ 0\\.013977661689504766\ \(0\)\
\-\ 38\\:\\ 0\\.013838415036246757\ \(0\)\
\-\ dwi\\:\\ 0\\.013795903662463353\ \(0\)\
\-\ deficit\\:\\ 0\\.013400605400310775\ \(0\)\
\-\ callosum\\:\\ 0\\.01332736056268445\ \(0\)\
\-\ advanced\\:\\ 0\\.013291389566796905\ \(0\)\
\-\ t2\\-weighted\\:\\ 0\\.01315161718612267\ \(0\)\
\-\ assess\\:\\ 0\\.013017990671164869\ \(0\)\
\-\ serial\\:\\ 0\\.012953317727556101\ \(0\)\
\-\ progression\\:\\ 0\\.012921490068384991\ \(0\)\
\-\ residual\\:\\ 0\\.012889992235450199\ \(0\)\
\-\ definitive\\:\\ 0\\.012827959190978445\ \(0\)\
\-\ corpus\\:\\ 0\\.012797411057685126\ \(0\)\
\-\ higher\\:\\ 0\\.012737220701161784\ \(0\)\
\-\ ischemic\\:\\ 0\\.012649112686349469\ \(0\)\
\-\ part\\:\\ 0\\.012591761670226723\ \(0\)\
\-\ enhance\\:\\ 0\\.012563486920493248\ \(0\)\
\-\ almost\\:\\ 0\\.012563486920493248\ \(0\)\
\-\ hypointense\\:\\ 0\\.012320196015710463\ \(0\)\
\-\ gadolinium\\:\\ 0\\.012320196015710463\ \(0\)\
\-\ ventricles\\:\\ 0\\.01221801786738528\ \(0\)\
\-\ 3\\:\\ 0\\.012163984964781396\ \(0\)\
\-\ major\\:\\ 0\\.012143577077086508\ \(0\)\
\-\ scans\\:\\ 0\\.012094943820714348\ \(0\)\
\-\ diagnosis\\:\\ 0\\.011928384989546625\ \(0\)\
\-\ require\\:\\ 0\\.011885239044158263\ \(0\)\
\-\ important\\:\\ 0\\.011668038545732291\ \(0\)\
\-\ from\\:\\ 0\\.01154804601660376\ \(0\)\
\-\ circumscribed\\:\\ 0\\.011544798137238825\ \(0\)\
\-\ infarct\\:\\ 0\\.011524735267842619\ \(0\)\
\-\ difficult\\:\\ 0\\.011368828597971645\ \(0\)\
\-\ recurrence\\:\\ 0\\.011331070178523143\ \(0\)\
\-\ weighted\\:\\ 0\\.011293775064262308\ \(0\)\
\-\ and\\/or\\:\\ 0\\.0109772393218532\ \(0\)\
\-\ recurrent\\:\\ 0\\.01096058441071452\ \(0\)\
\-\ features\\:\\ 0\\.01096058441071452\ \(0\)\
\-\ neurologic\\:\\ 0\\.010846487391507635\ \(0\)\
\-\ hyperintense\\:\\ 0\\.010783161899401733\ \(0\)\
\-\ administration\\:\\ 0\\.010783161899401733\ \(0\)\
\-\ \\,\\:\\ 0\\.010696750309193726\ \(0\)\
\-\ lesion\\:\\ 0\\.010580882832829512\ \(0\)\
\-\ reveals\\:\\ 0\\.010161847265334418\ \(0\)\
\-\ unknown\\:\\ 0\\.01013641185600154\ \(0\)\
\-\ causes\\:\\ 0\\.010111187531336814\ \(0\)\
\-\ about\\:\\ 0\\.010012332845301678\ \(0\)\
\-\ used\\:\\ 0\\.009964085583428456\ \(0\)\
\-\ presence\\:\\ 0\\.009427919812939603\ \(0\)\
\-\ very\\:\\ 0\\.009427919812939603\ \(0\)\
\-\ status\\:\\ 0\\.0092715116145339\ \(0\)\
\-\ biopsy\\:\\ 0\\.009214873074883771\ \(0\)\
\-\ effect\\:\\ 0\\.00919622569321959\ \(0\)\
\-\ or\\:\\ 0\\.009132426282343837\ \(0\)\
\-\ being\\:\\ 0\\.009051027285108081\ \(0\)\
\-\ underwent\\:\\ 0\\.008912449955860848\ \(0\)\
\-\ does\\:\\ 0\\.00886207012274774\ \(0\)\
\-\ neoplasm\\:\\ 0\\.008845460717057533\ \(0\)\
\-\ followed\\:\\ 0\\.008707829396288058\ \(0\)\
\-\ medial\\:\\ 0\\.00830790125711262\ \(0\)\
\-\ differential\\:\\ 0\\.008246078508671519\ \(0\)\
\-\ onset\\:\\ 0\\.008198848711018693\ \(0\)\
\-\ such\\:\\ 0\\.008119552552707758\ \(0\)\
\-\ examination\\:\\ 0\\.008074234150378617\ \(0\)\
\-\ no\\:\\ 0\\.007845995295171446\ \(0\)\
\-\ primary\\:\\ 0\\.007694177090868378\ \(0\)\
\-\ not\\:\\ 0\\.007506496484753406\ \(0\)\
\-\ y\\.o\\:\\ 0\\.007496594020020365\ \(0\)\
\-\ two\\:\\ 0\\.007438696770869318\ \(0\)\
\-\ focal\\:\\ 0\\.00741791369039028\ \(0\)\
\-\ following\\:\\ 0\\.007371664914593156\ \(0\)\
\-\ t2\\:\\ 0\\.007351333643618091\ \(0\)\
\-\ 4\\:\\ 0\\.007236996672276733\ \(0\)\
\-\ a\\:\\ 0\\.0072328231334699315\ \(0\)\
\-\ months\\:\\ 0\\.007094046488419658\ \(0\)\
\-\ up\\:\\ 0\\.0069843378451496145\ \(0\)\
\-\ more\\:\\ 0\\.0064959766240491375\ \(0\)\
\-\ physical\\:\\ 0\\.006372356442496165\ \(0\)\
\-\ 1\\:\\ 0\\.00618032330686841\ \(0\)\
\-\ woman\\:\\ 0\\.005999705007565065\ \(0\)\
\-\ demonstrate\\:\\ 0\\.0059770581803435885\ \(0\)\
\-\ mri\\:\\ 0\\.0059674038143301515\ \(0\)\
\-\ the\\:\\ 0\\.005882948285260672\ \(0\)\
\-\ it\\:\\ 0\\.0058384449377903245\ \(0\)\
\-\ contrast\\:\\ 0\\.00581390786263801\ \(0\)\
\-\ case\\:\\ 0\\.0056823842944293945\ \(0\)\
\-\ demonstrates\\:\\ 0\\.00567362067371789\ \(0\)\
\-\ lateral\\:\\ 0\\.005612972783053344\ \(0\)\
\-\ \\-\\:\\ 0\\.00556756370428074\ \(0\)\
\-\ right\\:\\ 0\\.0054810438243794325\ \(0\)\
\-\ surgical\\:\\ 0\\.005459640639062169\ \(0\)\
\-\ after\\:\\ 0\\.005373863837717941\ \(0\)\
\-\ presents\\:\\ 0\\.0053059097127900485\ \(0\)\
\-\ for\\:\\ 0\\.004432268380806779\ \(0\)\
\-\ on\\:\\ 0\\.004400553266659137\ \(0\)\
\-\ and\\:\\ 0\\.004377118680418686\ \(0\)\
\-\ be\\:\\ 0\\.0040053395846320035\ \(0\)\
\-\ as\\:\\ 0\\.0039288070087967406\ \(0\)\
\-\ to\\:\\ 0\\.003894238070908689\ \(0\)\
\-\ history\\:\\ 0\\.0035872782301127155\ \(0\)\
\-\ are\\:\\ 0\\.0035406500684790326\ \(0\)\
\-\ is\\:\\ 0\\.0034181810236153533\ \(0\)\
\-\ was\\:\\ 0\\.003003883046242209\ \(0\)\
\-\ this\\:\\ 0\\.002921389706121985\ \(0\)\
\-\ left\\:\\ 0\\.0029060950433827193\ \(0\)\
\-\ patient\\:\\ 0\\.002603622890323368\ \(0\)\
\-\ in\\:\\ 0\\.002561685289606413\ \(0\)\
\-\ of\\:\\ 0\\.002478804272297626\ \(0\)\
\-\ \\.\\:\\ 0\\.001402717231810035\ \(0\)\
\-\ with\\:\\ 0\\.001066907380758873\ \(0\)\
